SANTA FE SPRINGS, Calif., June 22, 2026 (GLOBE NEWSWIRE) — Juneteenth is a federal holiday observed annually on June 19th in the United States to commemorate the end of slavery. Nadula is honored to participate in this observance and to uphold the enduring values of freedom, community solidarity, and the pursuit of justice. In African […]
Category Archives: People
U.S. Market Forecast to Reach USD 0.93 Billion While Europe Approaches USD 0.81 Billion by 2035, Driven by Growing Adoption of Laser-Based and Clinical Dermatology Treatments. Austin, United States, June 21, 2026 (GLOBE NEWSWIRE) — “The Hyperpigmentation Treatment Market size was valued at USD 1.52 billion in 2025 and is projected to reach USD 2.85 […]
Educational initiative highlights treatment options that may help restore chewing function, speech, and long-term dental health for residents of St. Augustine and St. Johns County ST. AUGUSTINE, Fla., June 22, 2026 (GLOBE NEWSWIRE) — Missing teeth can affect more than a person’s appearance. Dental professionals note that tooth loss may influence chewing ability, speech, bite […]
PALO ALTO, Calif., June 22, 2026 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage, multi-product biopharmaceutical company focused on developing medicines for genetic conditions, announced today that additional positive data from PROPEL 3, the global Phase 3 pivotal study of oral infigratinib in children living with achondroplasia, will be […]
FAIR HAVEN, N.J. and ITHACA, N.Y., June 22, 2026 (GLOBE NEWSWIRE) — TETmedical, Inc., a clinical stage medical diagnostics company developing rapid tools for diagnosing acute neurological injury based on its patented Tethered Enzyme Technology (TET), today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its NSE-FAST® (Neuron […]
BURLINGTON, Mass. and JERUSALEM, June 22, 2026 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation technologies, today announced further expansion in the number of medical policies across the U.S. providing favorable coverage for its SWIFT™ Accelerated Deep TMS™ protocol. The announcement comes […]
Company’s presentation will provide updates on SkinJect® Phase 2b Pivotal Study in patients with Gorlin Syndrome and Teverelix® Groundbreaking PRECISION-E2 Phase 2a Endometriosis Study leveraging the UAE Genome Program PHILADELPHIA, June 22, 2026 (GLOBE NEWSWIRE) — Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”), a biotech/life sciences company focused on advancing the clinical development […]
Results from the Phase 3 VELA clinical trials at Week 52 in adults with moderate-to-severe hidradenitis suppurativa (HS) demonstrate sonelokimab’s (SLK) potential best-in-class and best-in-disease profile, with consistent responses that are higher than those observed in trials of competing agents at the end of their respective parental trials Namely, ~67% of patients treated with SLK […]
Florida-distributed gummy supplement brand details current ingredients, pricing, refund policy, and customer service processes for 2026 Largo, FL, June 20, 2026 (GLOBE NEWSWIRE) — These statements have not been evaluated by the U.S. Food and Drug Administration. JellyFil is not intended to diagnose, treat, cure, or prevent any disease. Consumers should consult a qualified healthcare […]
Aurora, Colorado-based dietary supplement company refreshes publicly available product disclosures, reaffirms its 60-day money-back guarantee, and details current ordering, shipping, and support processes for 2026 AURORA, CO, June 19, 2026 (GLOBE NEWSWIRE) — These statements have not been evaluated by the U.S. Food and Drug Administration. BreathEaseX is not intended to diagnose, treat, cure, or […]





